ESMO 2019: 3-year Update of the Checkmate 238 Phase 3 Trial for Adjuvant Therapy

ESMO 2019: 3-year Update of the Checkmate 238 Phase 3 Trial for Adjuvant Therapy

Publication date: Oct 29, 2019

Associate Professor Victoria Atkinson and Dr Jeffrey Weber discuss the highlights from ESMO Barcelona 2019 on the management of melanoma in the adjuvant setting.

Faculty:

Associate Professor Victoria Atkinson

Senior Medical Oncologist,

Princess Alexandra Hospital, Brisbane, QLD

Jeffrey Weber M.D. Ph.D.

Medical Oncologist (Melanoma and Immunotherapy)

Deputy Director, NYU Langone Perlmutter Cancer Center, New York

—–

Website: www.MDBriefCase.com

Facebook: https://www.facebook.com/mdbriefcase

Twitter: https://twitter.com/mdbriefcase

Instagram: https://www.instagram.com/mdbriefcase/

LinkedIn: https://www.linkedin.com/company/mdbriefcase/

Concepts Keywords
ABB Tumor
ABC Respected Stage melanoma
ABS Tumor parameters tumor
Adjuvant Disease
Adjuvant Therapy Brain metastases
Agilent Hypothyroidism
Air Adjuvant therapy melanoma
Arithmetic Millimeter tumor
Asthma Nature tumor
Asymptomatic Management melanoma
Australia Patients lesson melanoma
Barcelona Radiosurgery
Biomarker Hormone replacement
Biomarkers Immunotherapy
Bird Adjuvant therapy
Blood Health
Brain Tumor RTT
Breast Clinical medicine
Brisbane Adjuvant therapy
Cancer Analgesics
Checkmate Melanoma
Cog Cancer
Cross
Czech
Deductive
Diabetes
Diabetes Mellitus
Embolism
Enbrel
Endocrine
Gamut
Geneva
Gin
Hippie
Horizon
Hormone
Horn
Hypothyroidism
Immune Cell
Immunotherapy
Informed Consent
Instagram
James Larkin
LinkedIn
Lung
Lymph Node
Mab
Melanoma
Melanomas
Metastatic
Mutation
Myocarditis
Nepenthes
Nevel
Niva
NYU
Oncologist
Placebo
Plateau
Princess Alexandra Hospital
Radiosurgery
Regiment
Relapse
Sentinel Lymph Node
Spiel
Suppressor
Survival Curve
Targeted Therapy
Tiburon
TiVo
Toxicity
Tram
Tree
Tumor
United States
Urban Fantasy
Urban Legend
Vaccine
Victoria
Wild Type

Semantics

Type Source Name
disease MESH melanoma
disease DOID melanoma
pathway BSID Melanoma
disease MESH Cancer
disease DOID Cancer
drug DRUGBANK Coenzyme M

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *